217 related articles for article (PubMed ID: 34237399)
1. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison.
Wu JY; Li YJ; Hu XB; Huang S; Luo S; Tang T; Xiang DX
J Control Release; 2021 Aug; 336():510-521. PubMed ID: 34237399
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy.
Wang J; Tang W; Yang M; Yin Y; Li H; Hu F; Tang L; Ma X; Zhang Y; Wang Y
Biomaterials; 2021 Jun; 273():120784. PubMed ID: 33848731
[TBL] [Abstract][Full Text] [Related]
3. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy.
Wang Y; Huo Y; Zhao C; Liu H; Shao Y; Zhu C; An L; Chen X; Chen Z
J Control Release; 2024 Apr; 368():170-183. PubMed ID: 38382811
[TBL] [Abstract][Full Text] [Related]
4. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy.
Zhu Q; Ling X; Yang Y; Zhang J; Li Q; Niu X; Hu G; Chen B; Li H; Wang Y; Deng Z
Adv Sci (Weinh); 2019 Mar; 6(6):1801899. PubMed ID: 30937268
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy.
Chu L; Sun Y; Zhao Y; Wang A; Sun Y; Duan X; Li N; Xia H; Liu W; Sun K
Int J Pharm; 2024 May; 660():124262. PubMed ID: 38815637
[TBL] [Abstract][Full Text] [Related]
6. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
Zhan Q; Yi K; Cui X; Li X; Yang S; Wang Q; Fang C; Tan Y; Li L; Xu C; Yuan X; Kang C
Neuro Oncol; 2022 Nov; 24(11):1871-1883. PubMed ID: 35312010
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX
J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569
[TBL] [Abstract][Full Text] [Related]
8. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis.
Kanchanapally R; Deshmukh SK; Chavva SR; Tyagi N; Srivastava SK; Patel GK; Singh AP; Singh S
Int J Nanomedicine; 2019; 14():531-541. PubMed ID: 30666112
[TBL] [Abstract][Full Text] [Related]
9. The Landscape of Biomimetic Nanovesicles in Brain Diseases.
You Q; Liang F; Wu G; Cao F; Liu J; He Z; Wang C; Zhu L; Chen X; Yang Y
Adv Mater; 2024 Feb; 36(7):e2306583. PubMed ID: 37713652
[TBL] [Abstract][Full Text] [Related]
10. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
11. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
[TBL] [Abstract][Full Text] [Related]
12. Overcoming the blood-brain barrier by using a multistage exosome delivery system to inhibit central nervous system lymphoma.
Liu X; Xia T; Fang Y; Zuo H; Dong X; Xu P; Ouyang J
Nanomedicine; 2022 Apr; 41():102523. PubMed ID: 35092855
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound Facilitates Naturally Equipped Exosomes Derived from Macrophages and Blood Serum for Orthotopic Glioma Treatment.
Bai L; Liu Y; Guo K; Zhang K; Liu Q; Wang P; Wang X
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14576-14587. PubMed ID: 30900870
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation in vitro of doxorubicin loaded mimetic exosomes-based delivery system.
Suna He -; Haofeng Pan -; Xingyue Qian -; Junyang Zhang -; Runfang Zhang -
Pak J Pharm Sci; 2023 May; 36(3):895-900. PubMed ID: 37580940
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
16. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang SF; Zuo FF; Yin BC; Ye BC
Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
[TBL] [Abstract][Full Text] [Related]
17. Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine.
Zou Y; Liu Y; Yang Z; Zhang D; Lu Y; Zheng M; Xue X; Geng J; Chung R; Shi B
Adv Mater; 2018 Dec; 30(51):e1803717. PubMed ID: 30328157
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
[TBL] [Abstract][Full Text] [Related]
19. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
[No Abstract] [Full Text] [Related]
20. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
